Researchers have identified pathways in acute myeloid leukaemia (AML) resistance to FLT3 inhibitors, offering hope of new treatments.
According to the international team working on the project, a new generation of drugs could now prevent the resis...
16 days ago
Swiss researchers have revealed that mutations of the TP53 gene harm the prognosis for patients with acute myeloid leukaemia (AML) treated with chimeric antigen receptor (CAR)-T cell therapies.
However, in a proof-of-concept study, the Zurich-base...
20 days ago
